NCT00052156Unknown3 期
A Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Plus BCG Versus Placebo Plus BCG as a Post-Surgical Treatment for Stage IV Melanoma
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 670
- 试验地点
- 136
研究概览
简要总结
This is a Phase III study in patients with melanoma that has spread to the lymph nodes and/or a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (136)
Loading locations...
相似试验
Unknown
3 期
Vaccine Therapy for Patients With Stage III MelanomaMalignant MelanomaNCT00052130CancerVax Corporation1,118
招募中
3 期
Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma PatientsMultiple MyelomaNCT06514508Guangzhou Gloria Biosciences Co., Ltd.60
已完成
3 期
Obeticholic Acid Versus Placebo, in Combination with Ursodeoxycholic Acid in Patients with Primary Biliary CirrhosisPBCNCT06715319Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.100
撤回
3 期
A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)Major Depressive Disorder (MDD)NCT06735079MGGM LLC146
已完成
3 期
The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar LinesGlabellar Frown LinesNCT05364580Protox Inc.269